Literature DB >> 16997509

Multiple regulatory regions and tissue-specific transcription initiation mediate the expression of NEMO/IKKgamma gene.

Francesca Fusco1, Vincenzo Mercadante, Maria Giuseppina Miano, Matilde Valeria Ursini.   

Abstract

NEMO/IKKgamma gene, which is responsible of two allelic diseases in human, EDA-ID and IP, encodes for a protein with a central regulatory role in the activation of the NF-kB pathway. We here provide insights into the molecular mechanism governing NEMO/IKKgamma expression. We mapped 4 distinctive NEMO/IKKgamma transcription start sites each corresponding to an alternative first exon, controlled by two conserved promoters. A distal promoter, named promoter A, located 10 kb upstream of the coding region and a proximal promoter, promoter B, with strong bi-directional activity driving also the transcription of G6PD gene in the opposite direction. The promoter B is housekeeping, it is embedded in a CpG island, required for proper expression and it is down-regulated by methylation. The promoter A is active in cells of hepatic origin and it directs transcription of the main NEMO/IKKgamma 5' UTR alternative transcript in liver, which starts at a tissue-specific site. Qualitative and quantitative expression analysis revealed that each NEMO/IKKgamma 5' UTR alternative transcript has different expression profiles indicating that the control of NEMO/IKKgamma expression is mediated through tissue-specific transcription initiation sites and multiple regulatory regions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16997509     DOI: 10.1016/j.gene.2006.07.022

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  The LCR at the IKBKG locus is prone to recombine.

Authors:  Francesca Fusco; Michele D'Urso; Maria Giuseppina Miano; Matilde Valeria Ursini
Journal:  Am J Hum Genet       Date:  2010-04-09       Impact factor: 11.025

2.  Rescue of recurrent deep intronic mutation underlying cell type-dependent quantitative NEMO deficiency.

Authors:  Bertrand Boisson; Yoshitaka Honda; Masahiko Ajiro; Jacinta Bustamante; Matthieu Bendavid; Andrew R Gennery; Yuri Kawasaki; Jose Ichishima; Mitsujiro Osawa; Hiroshi Nihira; Takeshi Shiba; Takayuki Tanaka; Maya Chrabieh; Benedetta Bigio; Hong Hur; Yuval Itan; Yupu Liang; Satoshi Okada; Kazushi Izawa; Ryuta Nishikomori; Osamu Ohara; Toshio Heike; Laurent Abel; Anne Puel; Megumu K Saito; Jean-Laurent Casanova; Masatoshi Hagiwara; Takahiro Yasumi
Journal:  J Clin Invest       Date:  2018-12-18       Impact factor: 14.808

3.  Immune deficiency caused by impaired expression of nuclear factor-kappaB essential modifier (NEMO) because of a mutation in the 5' untranslated region of the NEMO gene.

Authors:  Jana L Mooster; Caterina Cancrini; Alessandra Simonetti; Paolo Rossi; Gigliola Di Matteo; Maria Luisa Romiti; Silvia Di Cesare; Luigi Notarangelo; Raif S Geha; Douglas R McDonald
Journal:  J Allergy Clin Immunol       Date:  2010-06-12       Impact factor: 10.793

4.  Hyper IgM syndrome presenting as chronic suppurative lung disease.

Authors:  Silvia Montella; Marco Maglione; Giuliana Giardino; Angela Di Giorgio; Loredana Palamaro; Virginia Mirra; Matilde Valeria Ursini; Mariacarolina Salerno; Claudio Pignata; Carlo Caffarelli; Francesca Santamaria
Journal:  Ital J Pediatr       Date:  2012-09-19       Impact factor: 2.638

5.  Ursolic acid from Trailliaedoxa gracilis induces apoptosis in medullary thyroid carcinoma cells.

Authors:  Victor Aguiriano-Moser; Bernhard Svejda; Zeng-Xia Li; Sonja Sturm; Hermann Stuppner; Elisabeth Ingolic; Harald Höger; Veronika Siegl; Nathalie Meier-Allard; Anton Sadjak; Roswitha Pfragner
Journal:  Mol Med Rep       Date:  2015-07-07       Impact factor: 2.952

Review 6.  The zinc finger domain of IKKγ (NEMO) protein in health and disease.

Authors:  Amde Selassie Shifera
Journal:  J Cell Mol Med       Date:  2010-10       Impact factor: 5.310

7.  Double hit of NEMO gene in preeclampsia.

Authors:  Agata Sakowicz; Tadeusz Pietrucha; Magda Rybak-Krzyszkowska; Hubert Huras; Agnieszka Gach; Bartosz Sakowicz; Mateusz Banaszczyk; Mariusz Grzesiak; Lidia Biesiada
Journal:  PLoS One       Date:  2017-06-27       Impact factor: 3.240

8.  A regulatory path associated with X-linked intellectual disability and epilepsy links KDM5C to the polyalanine expansions in ARX.

Authors:  Loredana Poeta; Francesca Fusco; Denise Drongitis; Cheryl Shoubridge; Genesia Manganelli; Stefania Filosa; Mariateresa Paciolla; Monica Courtney; Patrick Collombat; Maria Brigida Lioi; Jozef Gecz; Matilde Valeria Ursini; Maria Giuseppina Miano
Journal:  Am J Hum Genet       Date:  2012-12-13       Impact factor: 11.025

9.  ATP8B1 gene expression is driven by a housekeeping-like promoter independent of bile acids and farnesoid X receptor.

Authors:  Dita Cebecauerová; Sandra S Strautnieks; Jane A Byrne; Milan Jirsa; Richard J Thompson
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

10.  Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) gene.

Authors:  Margherita Gaviraghi; Andrea Caricasole; Chiara Costanzo; Daniela Diamanti; Mario Dandrea; Massimo Donadelli; Aldo Scarpa; Marta Palmieri
Journal:  BMC Mol Biol       Date:  2008-06-12       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.